ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,734Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 229

$1.28M Total Retail Price of All Prescriptions

Rank: 1 out of 229

834 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 834 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

19% of this provider’s 834 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 15,889 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
SIMVASTATIN 969 798 1 3
LEVOTHYROXINE SODIUM 903 729 2 1
METFORMIN HCL 818 661 3 6
LISINOPRIL 807 638 4 2
HYDROCODONE-ACETAMINOPHEN 707 442 S3 5 7
OMEPRAZOLE 654 527 6 4
LISINOPRIL-HYDROCHLOROTHIAZIDE 520 406 7 28
AMLODIPINE BESYLATE 365 324 8 5
GLIMEPIRIDE 351 292 9 63
MIRTAZAPINE 316 286 10 52
METOPROLOL TARTRATE 312 276 11 13
FUROSEMIDE 304 277 12 8
CRESTOR 296 244 13 30
TAMSULOSIN HCL 286 260 14 24
HYDROCHLOROTHIAZIDE 280 258 15 9
ALPRAZOLAM 238 204 16 133
GABAPENTIN 217 164 17 10
CARVEDILOL 217 189 17 31
ACTOS 212 203 19 105
METOPROLOL SUCCINATE 186 149 20 16
WARFARIN SODIUM 175 158 21 17
TRAMADOL HCL 169 99 22 26
ATORVASTATIN CALCIUM 168 144 23 15
GENERLAC 158 158 24 171
NEXIUM 155 100 25 48
PRAVASTATIN SODIUM 149 119 26 25
LOSARTAN-HYDROCHLOROTHIAZIDE 147 109 27 65
DONEPEZIL HCL 146 146 28 29
SYNTHROID 143 135 29 46
DIOVAN HCT 135 127 30 114
LOVASTATIN 134 125 31 11
JANUVIA 134 101 31 59
TRAZODONE HCL 128 92 33 34
GLYBURIDE 123 107 R 34 57
AZITHROMYCIN 122 96 35 53
AMITRIPTYLINE HCL 115 88 R 36 66
POTASSIUM CHLORIDE 111 101 37 18
DIOVAN 109 94 38 42
AMLODIPINE BESYLATE-BENAZEPRIL 108 101 39 120
IBUPROFEN 105 55 40 60
ALLOPURINOL 104 85 41 27
METHOCARBAMOL 103 67 R 42 137
CLOPIDOGREL 102 93 43 44
SERTRALINE HCL 98 51 44 22
ALENDRONATE SODIUM 97 90 45 14
PANTOPRAZOLE SODIUM 94 60 46 33
ZOLPIDEM TARTRATE 94 69 46 20
FLUTICASONE PROPIONATE 90 54 48 23
ACETAMINOPHEN-CODEINE 88 61 S3 49 79
SPIRONOLACTONE 88 62 49 56
TRIAMTERENE-HCTZ 87 73 51 51
CYCLOBENZAPRINE HCL 86 57 R 52 75
PLAVIX 85 75 53 72
PHENYTOIN SODIUM EXTENDED 85 64 53 136
FINASTERIDE 80 80 55 55
FLUOCINONIDE 80 64 55 212
FLUOXETINE HCL 79 41 57 41
BACLOFEN 79 49 57 107
OXYBUTYNIN CHLORIDE 79 47 57 97
DOXAZOSIN MESYLATE 78 77 60 50
FENOFIBRATE 77 67 61 68
GEMFIBROZIL 77 68 61 62
PIOGLITAZONE HCL 77 71 R 61 253
PROAIR HFA 77 52 61 38
PRADAXA 75 75 65 212
LEVEMIR FLEXPEN 71 42 66 146
OXYCODONE HCL-ACETAMINOPHEN 70 32 S2 67 73
PREDNISONE 68 62 68 35
NOVOLOG 66 32 69 116
LOSARTAN POTASSIUM 66 53 69 12
EXELON 66 66 69 162
BUPROPION HCL SR 65 27 72 121
NAMENDA 63 63 73 39
CARBIDOPA-LEVODOPA 63 63 73 82
LANTUS 63 58 73 40
OLANZAPINE 62 62 76 109
PAROXETINE HCL 62 55 76 49
EVISTA 62 62 76 106
LACTULOSE 61 58 79 66
FAMOTIDINE 60 45 80 84
DETROL LA 59 59 81 125
LANTUS SOLOSTAR 59 40 81 85
HALOPERIDOL 58 47 83 278
NIASPAN 58 40 83 166
PEN NEEDLE 58 38 83 110
LIPITOR 58 53 83 183
ZETIA 55 35 87 93
LORAZEPAM 55 55 87 160
ISOSORBIDE MONONITRATE ER 55 46 87 99
RANITIDINE HCL 54 47 90 32
NOVOLOG FLEXPEN 53 31 91 128
FENTANYL 53 49 S2 91 108
DILTIAZEM 24HR CD 52 52 93 89
CHOLESTYRAMINE 51 42 94 304
CIPROFLOXACIN HCL 50 47 95 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.